From January 1, 2022 to March 31, 2022, the company has repurchased 7,133,700 shares, representing 0.46% for ¥24,992.76 million. With this, the company has completed the repurchase of 22,469,400 shares, representing 1.43% for ¥74,972.7 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.86% | 41.26B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.